Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
9.76
+0.16 (1.67%)
At close: Jul 17, 2025, 4:00 PM
9.78
+0.02 (0.20%)
After-hours: Jul 17, 2025, 7:55 PM EDT

Company Description

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States.

It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products.

It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats.

The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.

Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings logo
CountryUnited States
Founded2008
IndustryBiotechnology
SectorHealthcare
Employees834
CEOJason Kelly

Contact Details

Address:
27 Drydock Avenue, 8th Floor
Boston, Massachusetts 02210
United States
Phone877 422 5362
Websiteginkgo.bio

Stock Details

Ticker SymbolDNA
ExchangeNYSE
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001830214
CUSIP Number37611X209
ISIN NumberUS37611X2099
Employer ID87-2652913
SIC Code2836

Key Executives

NamePosition
Dr. Jason Kelly Ph.D.Founder, Chief Executive Officer and Director
Dr. Reshma P. ShettyFounder, President, Chief Operating Officer and Director
Thomas Knight Jr.Founder
Austin Che Ph.D.Founder, Head of Strategy and Treasurer
Bartholomew Canton Ph.D.Founder, Chief Technology Officer and Secretary
Steven P. Coen CPAChief Accounting Officer and Chief Financial Officer
Karen TepichinGeneral Counsel and Secretary
Daniel MarshallSenior Manager of Communications and Ownership
Samantha SuttonHead of People
Joshua DunnHead of Design

Latest SEC Filings

DateTypeTitle
Jul 17, 2025SCHEDULE 13GFiling
Jul 17, 2025144Filing
Jul 9, 2025144Filing
Jun 23, 2025144Filing
Jun 20, 2025144Filing
Jun 18, 2025144Filing
Jun 17, 2025144Filing
Jun 16, 2025144Filing
Jun 13, 20258-KCurrent Report
Jun 13, 2025144Filing